GSK3228836

Ionis deal delivers for GSK as HBV drug hits the mark in phase 2
Pharmaforum
Fri, 08/28/20 - 10:36 am
GSK
antisense
hepatitis B
clinical trials
GSK3228836
Ionis Pharmaceuticals